Synthetic studies and pharmacological evaluations on the MDMA ('Ecstasy') antagonist nantenine. - Wikidata - wikimedia - TriplyDB

Synthetic studies and pharmacological evaluations on the MDMA ('Ecstasy') antagonist nantenine.

Synthetic studies and pharmacological evaluations on the MDMA ('Ecstasy') antagonist nantenine.

http://www.wikidata.org/entity/Q33638199

about

Evaluation of structural effects on 5-HT(2A) receptor antagonism by aporphines: identification of a new aporphine with 5-HT(2A) antagonist activity.Affinity of aporphines for the human 5-HT2A receptor: insights from homology modeling and molecular docking studies.Cytotoxicity of aporphines in human colon cancer cell lines HCT-116 and Caco-2: an SAR study New aporphinoid 5-HT2A and α1A antagonists via structural manipulations of nantenine C4 phenyl aporphines with selective h5-HT(2B) receptor affinity A New Route to Azafluoranthene Natural Products via Direct Arylation Facile total synthesis of lysicamine and the anticancer activities of the RuII, RhIII, MnII and ZnII complexes of lysicamine

P2860

Q33616439-8BFE2450-7C35-4DFE-BD25-3625ED6D1350 Q34052154-D3AED770-DAD4-4A4E-94E1-078A85351501 Q35164011-26DED2C6-91A7-442F-A58D-EBA350BCD2D3 Q35382061-45210BF9-C376-4F04-A3D6-458382F3DC0D Q35912288-4F9F323A-5A81-4EE5-852A-E1F33B08045F Q36683430-40B2005E-AA0E-4D79-94CA-A339B075CF76 Q41708811-16C7F84D-C65C-40D8-9648-44FC87DCCF31

P2860

Synthetic studies and pharmacological evaluations on the MDMA ('Ecstasy') antagonist nantenine.

http://www.wikidata.org/entity/Q33638199

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Synthetic studies and pharmaco ...... cstasy') antagonist nantenine.

@ast

Synthetic studies and pharmaco ...... cstasy') antagonist nantenine.

@en

type

label

Synthetic studies and pharmaco ...... cstasy') antagonist nantenine.

@ast

Synthetic studies and pharmaco ...... cstasy') antagonist nantenine.

@en

prefLabel

Synthetic studies and pharmaco ...... cstasy') antagonist nantenine.

@ast

Synthetic studies and pharmaco ...... cstasy') antagonist nantenine.

@en

P1433

Q33638199-B6B22E0C-02CF-44C8-8E69-22CFAC05D8EC

P1476

Q33638199-4C5B81AB-0D73-4147-A17B-31781E3E2E84

P2093

Q33638199-14A2E136-BF4F-40D9-88E8-F18BAE6D83F8

Q33638199-2639DCD8-5003-41E7-BC7E-82B613D824B7

Q33638199-5A3061DB-4233-4DCA-9762-6D73B6AC7E86

Q33638199-808E6FB7-5323-4D94-BAB9-AEDD9D8FE7AD

P2860

Q33638199-0618FAE5-3F86-41EA-9096-70D59D33CC2F

Q33638199-08BAD4B3-9ADC-469C-B913-983DFF09923C

Q33638199-0AB4658B-7656-431C-AA27-D94DFBA589BF

Q33638199-11153C0D-5515-4A96-B21D-6B441A9BE00B

Q33638199-25124ABB-4EE4-48C2-BA86-B3188421BF6F

Q33638199-2EF747A1-779A-473C-A262-EBB41743FDA4

Q33638199-3FC0E44C-36B4-4C80-8D41-65DAB336E2C7

Q33638199-4ECDAB73-9405-494C-9CE7-CC6E603FC855

Q33638199-5035E614-34A5-42EE-93E9-D3B2430A647A

Q33638199-53E0064A-01A9-446B-9F9C-10CBD1769BBE

P304

Q33638199-15EC4BC4-C965-40ED-8E25-E1D68312F609

P31

Q33638199-6A49CFE9-0161-4931-9DEC-39F1951EB951

P356

Q33638199-81D6A8F8-5E01-4807-913D-99DFFA426A44

P407

Q33638199-F3B0750C-F465-4F07-93A5-DE05005A1B88

P433

Q33638199-F91097DF-4031-41ED-A9EE-FF2CA3DA3370

P478

Q33638199-709877DC-71CC-4483-BC16-01D3B7FDDEBD

P50

Q33638199-934DE418-A9C6-4E48-ABD6-F6A42A1F8A3E

Q33638199-F9C946F8-82F0-4941-932F-7F4BFD8442DC

P577

Q33638199-29F94AFA-4984-416C-82BC-DE72DE5638B8

P5875

Q33638199-9444FA9D-8009-4BF5-B608-FAE8F90634E4

P698

Q33638199-91ACCE69-5862-48EB-BE90-C8744AA98EFA

P932

Q33638199-73E4830C-667F-4AF1-B172-E0107C490881

P356

J.BMCL.2009.11.053

P1433

Bioorganic & Medicinal Chemistry Letters

P1476

Synthetic studies and pharmaco ...... Ecstasy') antagonist nantenine

@en

P2093

Onica Legendre

http://www.w3.org/2001/XMLSchema#string

Sarah M Zimmerman

http://www.w3.org/2001/XMLSchema#string

Wayne W Harding

http://www.w3.org/2001/XMLSchema#string

William E Fantegrossi

http://www.w3.org/2001/XMLSchema#string

P2860

(+/-)-Nantenine analogs as antagonists at human 5-HT(2A) receptors: C1 and flexible congeners

Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice

Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin.

Structure-activity relationship studies with (+/-)-nantenine derivatives for alpha1-adrenoceptor antagonist activity.

Memory deficits associated with recreational use of "ecstasy" (MDMA).

Hyperthermia induced by 3,4-methylenedioxymethamphetamine in unrestrained rhesus monkeys.

Alpha1-adrenergic receptors mediate the locomotor response to systemic administration of (+/-)-3,4-methylenedioxymethamphetamine (MDMA) in rats

Adolescent ecstasy and other drug use in the National Survey of Parents and Youth: the role of sensation-seeking, parental monitoring and peer's drug use.

Microwave-Assisted Direct Biaryl Coupling: First Application to the Synthesis of Aporphines.

Biological evaluation of compounds for their physical dependence potential and abuse liability. X. Drug testing programs of the Committee on Problems of Drug Dependence, Inc. (1986).

P304

628-631

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BMCL.2009.11.053

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Sandeep Chaudhary

P577

2009-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40450354

http://www.w3.org/2001/XMLSchema#string

P698

19963380

http://www.w3.org/2001/XMLSchema#string

P932

2818532

http://www.w3.org/2001/XMLSchema#string